RecruitingNot ApplicableNCT05265169

Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)

Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial for Microwave Ablation as a Local Cure


Sponsor

Society of Interventional Oncology

Enrollment

275 participants

Start Date

Jan 13, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Microwave ablation for people with colorectal liver metastases. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMicrowave ablation

Microwave ablation of colorectal liver metastases (CLM)


Locations(7)

Miami Cancer Institute

Miami, Florida, United States

Mayo Clinic

Rochester, Minnesota, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

MD Anderson Cancer Center

Houston, Texas, United States

Medical College of WI

Milwaukee, Wisconsin, United States

National and Kapodistrian University of Athens (NKUA)

Athens, Greece

Amsterdam UMC

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05265169


Related Trials